Display options
Cite
Ueda P, Pasternak B, Eliasson B, et al. Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries. Diabetes Care. 2019;42(6):e92-e94doi: 10.2337/dc18-2532.
Ueda, P., Pasternak, B., Eliasson, B., Svensson, A. M., Franzén, S., Gudbjörnsdottir, S., Hveem, K., Jonasson, C., Melbye, M., & Svanström, H. (2019). Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries. Diabetes care, 42(6), e92-e94. https://doi.org/10.2337/dc18-2532
Ueda, Peter, et al. "Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries." Diabetes care vol. 42,6 (2019): e92-e94. doi: https://doi.org/10.2337/dc18-2532
Ueda P, Pasternak B, Eliasson B, Svensson AM, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Melbye M, Svanström H. Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries. Diabetes Care. 2019 Jun;42(6):e92-e94. doi: 10.2337/dc18-2532. Epub 2019 Apr 22. PMID: 31010872.
Copy Download .nbib Format: NLM
Share it on

Diabetes Care. 2019 Jun;42(6):e92-e94. doi: 10.2337/dc18-2532. Epub 2019 Apr 22.

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries.

Diabetes care

Peter Ueda, Björn Pasternak, Björn Eliasson, Ann-Marie Svensson, Stefan Franzén, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Mads Melbye, Henrik Svanström

Affiliations

  1. Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden [email protected].
  2. Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  3. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  4. Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  5. Swedish National Diabetes Register, Västra Götalandsregionen, Gothenburg, Sweden.
  6. Health Metrics, Department of Public Health and Community Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  7. K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.
  8. Faculty of Medicine, HUNT Research Center, NTNU-Norwegian University of Science and Technology, Levanger, Norway.
  9. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  10. Department of Medicine, Stanford University School of Medicine, Stanford, CA.

PMID: 31010872 DOI: 10.2337/dc18-2532

[No abstract available.]

Publication Types